SG Americas Securities
INFI

SG Americas Securities’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

SG Americas Securities’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-23,907
Closed -$15K – 3667
2022
Q2 		$15K Buy
23,907
+9,058
+61% +$6.95K ﹤0.01% 3356
2022
Q1 		$17K Sell
14,849
-24,241
-62% -$29K ﹤0.01% 2892
2021
Q4 		$88K Sell
39,090
-16,179
-29% -$40.6K ﹤0.01% 3109
2021
Q3 		$189K Buy
+55,269
New +$170K ﹤0.01% 3272
2016
Q4 		– Sell
-111,811
Closed -$174K – 3555
2016
Q3 		$174K Buy
111,811
+73,458
+192% +$113K ﹤0.01% 2612
2016
Q2 		$51K Buy
38,353
+16,256
+74% +$76K ﹤0.01% 2452
2016
Q1 		$116K Buy
+22,097
New +$135K ﹤0.01% 2540
2015
Q1 		– Sell
-12,923
Closed -$218K – 3163
2014
Q4 		$218K Sell
12,923
-2,290
-15% -$33.3K ﹤0.01% 2356
2014
Q3 		$204K Sell
15,213
-22,386
-60% -$267K ﹤0.01% 1981
2014
Q2 		$479K Sell
37,599
-9,526
-20% -$99.2K ﹤0.01% 1698
2014
Q1 		$560K Buy
47,125
+9,300
+25% +$125K ﹤0.01% 1419
2013
Q4 		$522K Sell
37,825
-38,345
-50% -$542K ﹤0.01% 1535
2013
Q3 		$1.33M Sell
76,170
-32,313
-30% -$619K 0.01% 1140
2013
Q2 		$1.76M Buy
+108,483
New +$3.36M 0.01% 851

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
MIAN
Mariner Independent Advisor Network Overland Park, Kansas $2.33B AUM 14.85% 1-Year Est. Return
GC
Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Americas Securities's INFI Position: Q3 2022 in Review

SG Americas Securities sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2022, closing a stake of 23,907 shares — an estimated $15K sold.

SG Americas Securities first reported a position in INFI in Q2 2013 and held it in 14 quarters. The position peaked at $1.76M in Q2 2013. 76 funds tracked by Wall St. Rank hold INFI as of Q3 2022.

  • SG Americas Securities reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2022 after selling out during the quarter.
  • SG Americas Securities sold 23,907 Infinity Pharmaceuticals, Inc. shares in Q3 2022, an estimated $15K.
  • SG Americas Securities first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
  • SG Americas Securities's Infinity Pharmaceuticals, Inc. position peaked at $1.76M in Q2 2013.
  • 76 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2022.

Based on SG Americas Securities's 13F filing for Q3 2022, filed 31 Oct 2022.